Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Marion DeJong
Introduction
Marion DeJong is a notable inventor based in Vlaardingen, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of compounds that interact with specific receptors in the body. Her work has implications for various therapeutic applications.
Latest Patents
Marion DeJong holds a patent for her invention titled "RGD (Arg-Gly-Asp) coupled to (neuro)peptides." This invention relates to compounds that exhibit a binding affinity for both the αvβ3 receptor and a (neuro)peptide receptor, specifically the somatostatin receptor. The compound consists of a first peptide part that includes the amino acid sequence Arg-Gly-Asp, and a second peptide part that is coupled to it, potentially via a linker. This second part is a (neuro)peptide, showcasing her innovative approach to peptide design.
Career Highlights
Marion DeJong is associated with Biosynthema Inc., where she continues to advance her research and development efforts. Her work at the company reflects her commitment to exploring new frontiers in biotechnology and peptide research.
Collaborations
Throughout her career, Marion has collaborated with esteemed colleagues, including Eric Paul Krenning and Petrus Martinus Van Hagen. These collaborations have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Marion DeJong's contributions to the field of biotechnology through her patent and collaborative efforts highlight her role as a pioneering inventor. Her work continues to inspire advancements in therapeutic applications and peptide research.